HEADER IMMUNE SYSTEM 21-JUL-09 3IDI TITLE CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL TITLE 2 ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE TITLE 3 ALDKWNQ COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2F5 FAB LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: 2F5 FAB HEAVY CHAIN; COMPND 6 CHAIN: B; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: GP41 MPER PEPTIDE; COMPND 9 CHAIN: C; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_TAXID: 9606; SOURCE 7 MOL_ID: 3; SOURCE 8 SYNTHETIC: YES KEYWDS HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.-P.JULIEN,S.BRYSON,E.F.PAI REVDAT 1 02-MAR-10 3IDI 0 JRNL AUTH S.BRYSON,J.P.JULIEN,R.C.HYNES,E.F.PAI JRNL TITL CRYSTALLOGRAPHIC DEFINITION OF THE EPITOPE JRNL TITL 2 PROMISCUITY OF THE BROADLY NEUTRALIZING ANTI-HUMAN JRNL TITL 3 IMMUNODEFICIENCY VIRUS TYPE 1 ANTIBODY 2F5: VACCINE JRNL TITL 4 DESIGN IMPLICATIONS. JRNL REF J.VIROL. V. 83 11862 2009 JRNL REFN ISSN 0022-538X JRNL PMID 19740978 JRNL DOI 10.1128/JVI.01604-09 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1041152.510 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 25395 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1278 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3585 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 211 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3310 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 209 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.01000 REMARK 3 B22 (A**2) : -1.59000 REMARK 3 B33 (A**2) : -0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 28.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.04 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.360 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.940 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.800 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 48.49 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : GOL.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : GOL.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3IDI COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-09. REMARK 100 THE RCSB ID CODE IS RCSB054275. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : RIGAKU OPTICS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25395 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 25.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39200 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE, PH 5.6, 16% REMARK 280 2-PROPANOL, 16% PEG 4000, 0.1% TWEEN-20, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.75000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.10000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.25000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.10000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.75000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.25000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 214 REMARK 465 THR B 100 REMARK 465 LEU B 100A REMARK 465 PHE B 100B REMARK 465 GLY B 100C REMARK 465 VAL B 100D REMARK 465 PRO B 100E REMARK 465 ILE B 100F REMARK 465 ALA B 100G REMARK 465 ARG B 100H REMARK 465 SER B 128 REMARK 465 LYS B 129 REMARK 465 SER B 130 REMARK 465 THR B 131 REMARK 465 SER B 132 REMARK 465 GLY B 133 REMARK 465 LYS B 214 REMARK 465 SER B 215 REMARK 465 CYS B 216 REMARK 465 ASP B 217 REMARK 465 LYS B 218 REMARK 465 GLN C 6 REMARK 465 ASN C 7 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ALA B 125 O HOH B 258 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 263 O HOH A 264 2555 2.01 REMARK 500 OE1 GLU A 70 OG1 THR B 17 3545 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 30 -116.76 49.31 REMARK 500 ALA A 51 -35.11 68.16 REMARK 500 ALA A 84 -164.42 -162.12 REMARK 500 ASN A 138 73.51 45.50 REMARK 500 THR B 15 -30.59 92.51 REMARK 500 LEU B 29 7.91 -69.24 REMARK 500 ASP B 31 28.47 -45.42 REMARK 500 PHE B 32 118.33 64.91 REMARK 500 ARG B 82B 61.57 35.47 REMARK 500 ALA B 100M 170.03 167.05 REMARK 500 PHE B 146 136.09 -170.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASP B 31 22.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 215 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 219 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D0L RELATED DB: PDB REMARK 900 RELATED ID: 2P8M RELATED DB: PDB REMARK 900 RELATED ID: 3IDG RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE REMARK 900 ALDKWD REMARK 900 RELATED ID: 3IDJ RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE REMARK 900 ANALOG ELD(ORN)WAS REMARK 900 RELATED ID: 3IDM RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE REMARK 900 ANALOG ELD(NRG)WAS REMARK 900 RELATED ID: 3IDN RELATED DB: PDB REMARK 900 SAME MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE REMARK 900 ANALOG ELD(PAF)WAS DBREF 3IDI A 1 214 PDB 3IDI 3IDI 1 214 DBREF 3IDI B 1 218 PDB 3IDI 3IDI 1 218 DBREF 3IDI C 1 7 PDB 3IDI 3IDI 1 7 SEQRES 1 A 214 ALA LEU GLN LEU THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 A 214 SER VAL GLY ASP ARG ILE THR ILE THR CYS ARG ALA SER SEQRES 3 A 214 GLN GLY VAL THR SER ALA LEU ALA TRP TYR ARG GLN LYS SEQRES 4 A 214 PRO GLY SER PRO PRO GLN LEU LEU ILE TYR ASP ALA SER SEQRES 5 A 214 SER LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 A 214 GLY SER GLY THR GLU PHE THR LEU THR ILE SER THR LEU SEQRES 7 A 214 ARG PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN LEU SEQRES 8 A 214 HIS PHE TYR PRO HIS THR PHE GLY GLY GLY THR ARG VAL SEQRES 9 A 214 ASP VAL ARG ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 A 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 A 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 A 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 A 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 A 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 A 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR GLU CYS GLU SEQRES 16 A 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 A 214 PHE ASN ARG GLY GLU CYS SEQRES 1 B 237 ARG ILE THR LEU LYS GLU SER GLY PRO PRO LEU VAL LYS SEQRES 2 B 237 PRO THR GLN THR LEU THR LEU THR CYS SER PHE SER GLY SEQRES 3 B 237 PHE SER LEU SER ASP PHE GLY VAL GLY VAL GLY TRP ILE SEQRES 4 B 237 ARG GLN PRO PRO GLY LYS ALA LEU GLU TRP LEU ALA ILE SEQRES 5 B 237 ILE TYR SER ASP ASP ASP LYS ARG TYR SER PRO SER LEU SEQRES 6 B 237 ASN THR ARG LEU THR ILE THR LYS ASP THR SER LYS ASN SEQRES 7 B 237 GLN VAL VAL LEU VAL MET THR ARG VAL SER PRO VAL ASP SEQRES 8 B 237 THR ALA THR TYR PHE CYS ALA HIS ARG ARG GLY PRO THR SEQRES 9 B 237 THR LEU PHE GLY VAL PRO ILE ALA ARG GLY PRO VAL ASN SEQRES 10 B 237 ALA MET ASP VAL TRP GLY GLN GLY ILE THR VAL THR ILE SEQRES 11 B 237 SER SER THR SER THR LYS GLY PRO SER VAL PHE PRO LEU SEQRES 12 B 237 ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA SEQRES 13 B 237 LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL SEQRES 14 B 237 THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL SEQRES 15 B 237 HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SEQRES 16 B 237 SER LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU SEQRES 17 B 237 GLY THR GLN THR TYR THR CYS ASN VAL ASN HIS LYS PRO SEQRES 18 B 237 SER ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SER SEQRES 19 B 237 CYS ASP LYS SEQRES 1 C 7 ALA LEU ASP LYS TRP GLN ASN HET SO4 A 215 5 HET SO4 B 219 5 HET GOL B 300 6 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL FORMUL 4 SO4 2(O4 S 2-) FORMUL 6 GOL C3 H8 O3 FORMUL 7 HOH *209(H2 O) HELIX 1 1 ARG A 79 PHE A 83 5 5 HELIX 2 2 SER A 121 LYS A 126 1 6 HELIX 3 3 LYS A 183 HIS A 189 1 7 HELIX 4 4 PRO B 61 ASN B 64 5 4 HELIX 5 5 SER B 83 THR B 87 5 5 HELIX 6 6 SER B 156 ALA B 158 5 3 HELIX 7 7 SER B 187 LEU B 189 5 3 HELIX 8 8 LYS B 201 ASN B 204 5 4 SHEET 1 A 4 LEU A 4 SER A 7 0 SHEET 2 A 4 ILE A 19 ALA A 25 -1 O ARG A 24 N THR A 5 SHEET 3 A 4 GLU A 70 ILE A 75 -1 O LEU A 73 N ILE A 21 SHEET 4 A 4 PHE A 62 SER A 67 -1 N SER A 63 O THR A 74 SHEET 1 B 6 SER A 10 ALA A 13 0 SHEET 2 B 6 THR A 102 VAL A 106 1 O ARG A 103 N LEU A 11 SHEET 3 B 6 THR A 85 GLN A 90 -1 N TYR A 86 O THR A 102 SHEET 4 B 6 LEU A 33 GLN A 38 -1 N ALA A 34 O GLN A 89 SHEET 5 B 6 GLN A 45 TYR A 49 -1 O LEU A 47 N TRP A 35 SHEET 6 B 6 SER A 53 LEU A 54 -1 O SER A 53 N TYR A 49 SHEET 1 C 4 SER A 114 PHE A 118 0 SHEET 2 C 4 THR A 129 PHE A 139 -1 O VAL A 133 N PHE A 118 SHEET 3 C 4 TYR A 173 SER A 182 -1 O TYR A 173 N PHE A 139 SHEET 4 C 4 SER A 159 VAL A 163 -1 N GLN A 160 O THR A 178 SHEET 1 D 4 ALA A 153 LEU A 154 0 SHEET 2 D 4 LYS A 145 VAL A 150 -1 N VAL A 150 O ALA A 153 SHEET 3 D 4 VAL A 191 THR A 197 -1 O GLU A 195 N GLN A 147 SHEET 4 D 4 VAL A 205 ASN A 210 -1 O VAL A 205 N VAL A 196 SHEET 1 E 4 THR B 3 SER B 7 0 SHEET 2 E 4 LEU B 18 SER B 25 -1 O THR B 21 N SER B 7 SHEET 3 E 4 GLN B 77 MET B 82 -1 O MET B 82 N LEU B 18 SHEET 4 E 4 LEU B 67 ASP B 72 -1 N ASP B 72 O GLN B 77 SHEET 1 F 6 LEU B 11 VAL B 12 0 SHEET 2 F 6 ILE B 107 ILE B 111 1 O THR B 110 N VAL B 12 SHEET 3 F 6 ALA B 88 ARG B 95 -1 N TYR B 90 O ILE B 107 SHEET 4 F 6 GLY B 35 GLN B 39 -1 N ILE B 37 O PHE B 91 SHEET 5 F 6 GLU B 46 TYR B 52 -1 O ALA B 49 N TRP B 36 SHEET 6 F 6 LYS B 57 TYR B 59 -1 O ARG B 58 N ILE B 50 SHEET 1 G 4 LEU B 11 VAL B 12 0 SHEET 2 G 4 ILE B 107 ILE B 111 1 O THR B 110 N VAL B 12 SHEET 3 G 4 ALA B 88 ARG B 95 -1 N TYR B 90 O ILE B 107 SHEET 4 G 4 VAL B 102 TRP B 103 -1 O VAL B 102 N HIS B 94 SHEET 1 H 4 SER B 120 LEU B 124 0 SHEET 2 H 4 THR B 135 TYR B 145 -1 O LEU B 141 N PHE B 122 SHEET 3 H 4 TYR B 176 PRO B 185 -1 O VAL B 184 N ALA B 136 SHEET 4 H 4 VAL B 163 THR B 165 -1 N HIS B 164 O VAL B 181 SHEET 1 I 4 SER B 120 LEU B 124 0 SHEET 2 I 4 THR B 135 TYR B 145 -1 O LEU B 141 N PHE B 122 SHEET 3 I 4 TYR B 176 PRO B 185 -1 O VAL B 184 N ALA B 136 SHEET 4 I 4 VAL B 169 LEU B 170 -1 N VAL B 169 O SER B 177 SHEET 1 J 3 THR B 151 TRP B 154 0 SHEET 2 J 3 TYR B 194 HIS B 200 -1 O ASN B 197 N SER B 153 SHEET 3 J 3 THR B 205 VAL B 211 -1 O VAL B 207 N VAL B 198 SSBOND 1 CYS A 23 CYS A 88 1555 1555 2.04 SSBOND 2 CYS A 134 CYS A 194 1555 1555 2.03 SSBOND 3 CYS B 22 CYS B 92 1555 1555 2.04 SSBOND 4 CYS B 140 CYS B 196 1555 1555 2.03 CISPEP 1 SER A 7 PRO A 8 0 -0.58 CISPEP 2 TYR A 94 PRO A 95 0 0.01 CISPEP 3 TYR A 140 PRO A 141 0 0.37 CISPEP 4 PHE B 146 PRO B 147 0 -0.17 CISPEP 5 GLU B 148 PRO B 149 0 -0.29 SITE 1 AC1 5 ARG A 37 LYS A 39 PRO A 59 ARG A 61 SITE 2 AC1 5 GLU A 81 SITE 1 AC2 2 LYS A 190 ARG A 211 SITE 1 AC3 11 GLN A 160 GLU A 161 SER A 162 SER A 176 SITE 2 AC3 11 THR A 178 PHE B 166 PRO B 167 SER B 177 SITE 3 AC3 11 LEU B 178 SER B 179 HOH B 230 CRYST1 63.500 76.500 94.200 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015748 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013072 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010616 0.00000